pH dependency of μ-calpain and m-calpain activity assayed by casein zymography following traumatic brain injury in the rat

Neuroscience Letters

Volumn 247, Issue 1, 1998, Pages 53-57

  Zhao, X ^a   Newcomb, J K ^a   Posmantur, R M ^b   Wang, K K W ^b   Pike, B R ^a   Hayes, R L ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b PFIZER INC   (United States)

Author keywords

Calpain; Casein zymography; Proteolysis; Traumatic brain injury

Indexed keywords

CALPAIN; CASEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; ENZYME ACTIVITY; ENZYME ANALYSIS; NEUROPATHOLOGY; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ANIMALS; BRAIN INJURIES; CALPAIN; CASEINS; ENDOPEPTIDASES; ENZYME ACTIVATION; ENZYME PRECURSORS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; RATS;

EID: 0032496059     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00219-5     Document Type: Article

References (36)

1. Bryan R.M., Cherian L., Robertson C. Regional cerebral blood flow after controlled cortical impact in rats. Anesth. Analg. 80:1995;687-695.
2. Chesler M., Kaila K. Activity-dependent modulation of extracellular pH in the central nervous system. Trends Neurosci. 15:1992;396-402.
3. Dixon C.E., Clifton G.L., Yaghmai A.A., Hayes R.L. Comparison of cortical impact model of traumatic brain injury in the rat. J. Neurosci. Meth. 39:1991;253-262.
4. 45Ca autoradiographic study. Brain Res. 624:1993;94-102.
5. Hayes R.L., Jenkins L.W., Lyeth B.G. Neurotransmitter mediated mechanisms of traumatic brain injury. J. Neurotrauma. 9:1992;173-187.
6. Hicks R.R., Smith D.H., McIntosh T.K. Temporal response and effects of excitatory amino acid antagonism on microtubule associated protein 2 immunoreactivity following experimental brain injury in rats. Brain Res. 678:1995;151-160.
7. Ishige N., Pitts L.H., Berry I., Nishimura M.C., James T.L. The effects of hypovolemic hypotension on high-energy phosphate metabolism of traumatized brain in rats. J. Neurosurg. 68:1988;129-136.
8. Ishige N., Pitts L.H., Pogliani L., Hashimoto T., Nishimura M.C., Bartkowski H.M., James T.L. Effect of hypoxia of traumatic brain injury in rats. Part 2: changes in high energy phosphate metabolism. Neurosurgery. 20:1987;854-858.
9. Kampfl A., Posmantur R.M., Nixon R., Grynspan F., Zhao X., Liu S.J., Newcomb J.K., Clifton G.L., Hayes R.L. μ-Calpain activation and calpain mediated cytoskeletal proteolysis following traumatic brain injury. J. Neurochem. 67:1996;1575-1583.
10. Kampfl A., Posmantur R.M., Zhao X., Schmutzhard E., Clifton G.L., Hayes R.L. Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy. A review and update. J. Neurotrauma. 14:1997;121-134.
11. Kerlero de Rosbo N., Carnegie P.R., Bernard C.C. Quantitative electroimmunoblotting study of the calcium-activated neutral protease in human myelin. J. Neurochem. 47:1986;1007-1012.
12. Malik M.N., Fenko M.D., Sheikh A.M., Kascsak R.J., Tonna-DeMasi M.S., Wisniewski H.M. Third form of calcium-activated neutral proteinase from calf brain: purification, partial characterization and comparison of properties with other forms. Biochim. Biophys. Acta. 916:1987;135-144.
13. Marmarou A. Intracellular acidosis in human and experimental brain injury. J. Neurotrauma. 9:1992;551-562.
14. 31P nuclear magnetic resonance. J. Neurochem. 49:1987;1530-1540.
15. McIntosh T.K., Smith D.H., Grade E. Therapeutic approaches for the prevention of secondary brain injury. Eur. J. Anaesthesiol. 13:1996;291-309.
16. Michetti M., Salamino F., Tedesco I., Averna M., Minafra R., Melloni E., Pontremoli S. Autolysis of human erythrocyte calpain produces two active enzyme forms with different cell localization. FEBS Lett. 392:1996;11-15.
17. Newcomb J.K., Kampfl A., Posmantur R.M., Zhao X., Pike B.R., Liu S.J., Clifton G.L., Hayes R.L. Immunohistochemical study of calpain-mediated breakdown products to α-spectrin following controlled cortical impact injury in the rat. J. Neurotrauma. 14:1997;369-383.
18. Nilsson E., Karlsson J.O. Characterization of brain calpains. J. Neurochem. 47:1986;1086-1090.
19. Nilsson E., Ostwald K., Karlsson J.O. Changes in brain calpain activity as a result of in vitro ischemia and pH alterations. Mol. Chem. Neuropathol. 14:1991;99-111.
20. 2+ levels following cortical compression contusion trauma in rats. J. Cereb. Blood Flow Metab. 13:1993;185-192.
21. Posmantur R.M., Hayes R.L., Dixon C.E., Taft W.C. Neurofilament 68 and 200 protein levels decrease after traumatic brain injury. J. Neurotrauma. 11:1994;533-545.
22. Posmantur R.M., Kampfl A., Liu S.J., Heck K., Taft W.C., Clifton G.L., Hayes R.L. Cytoskeletal derangements of cortical neuronal processes three hours after traumatic brain injury in rats: an immunofluorescence study. J. Neuropath. Exp. Neurol. 55:1996;68-80.
23. Posmantur R.M., Kampfl A., Siman R., Liu S.J., Zhao X., Clifton G.L., Hayes R.L. A calpain inhibitor attenuates cortical cytoskeletal protein loss after traumatic brain injury in rat. Neuroscience. 77:1997;875-888.
24. Posmantur R.M., Kampfl A., Taft W.C., Bhattachargee M., Dixon C.E., Bao J., Hayes R.L. Diminished microtubule-associated protein 2 (MAP2) immunoreactivity following cortical impact brain injury. J. Neurotrauma. 13(MAP2):1996;125-137.
25. Raser K.J., Posner A., Wang K.K.W. Casein zymography: a method to study μ-calpain, m-calpain, and their inhibitory agents. Arch. Biochem. Biophys. 319:1995;211-216.
26. Rosner M.J., Becker D.P. Experimental brain injury: successful therapy with the weak base, tromethamine. J. Neurosurg. 60:1984;961-971.
27. Saatman K.E., Bozyczko-Coyne D., Siman R., Marcy V., Gennarelli T.A., McIntosh T.K. Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropath. Exp. Neurol. 55:1996;852-862.
28. Saatman K.E., Murai H., Bartus R.T., Smith D.H., Hayward N.J., Perri B.R., McIntosh T.K. Calpain inhibitor AK 295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc. Natl. Acad. Sci. USA. 93:1996;3428-3433.
29. Shapira Y., Yadid G., Cotex S., Shahoami E. Accumulation of calcium in the brain following head trauma. Neurological Res. 11:1989;169-172.
30. Taft W.C., Yang K., Dixon C.E., Clifton G.L., Hayes R.L. Microtubule associated protein 2 level in hippocampus following traumatic brain injury. J. Cereb. Blood Flow Metab. 13:1993;796-802.
31. 31P MRS study. J. Cereb. Blood Flow Metab. 17:1997;50-53.
32. 31P magnetic resonance spectroscopy study. J. Cereb. Blood Flow Metab. 7:1987;563-571.
33. Vitto A., Nixon R.A. Calcium-activated neutral proteases of human brain: Subunit structure and enzymatic properties of multiple molecular forms. J. Neurochem. 47:1986;1039-1051.
34. Yang M.S., DeWitt D.S., Becker D.P., Hayes R.L. Regional brain metabolite levels following mild experimental head injury in the cat. J. Neurosurg. 63:1985;617-621.
35. Yuen P.W., Wang K.K.W. Therapeutic potential of calpain inhibitors in neurodegenerative disorders. Exp. Opin. Invest. Drugs. 5:1996;1291-1304.
36. Zhao X., Posmantur R.M., Kampfl A., Liu S.J., Wang K.K.W., Newcomb J.K., Pike B.R., Clifton G.L., Hayes R.L. Subcellular localization and duration of μ-calpain and m-calpain activity following traumatic brain injury in the rat: a casein zymography study. J. Cereb. Blood Flow Metab. 18(2):1998;161-167.